DIDACTIC LECTURES

Carol L. Shields, MD

Carol L. Shields, MD

Co-Director of the Oncology Service, Wills Eye Hospital, and Professor of Ophthalmology at Thomas Jefferson University in Philadelphia.

Dr. Carol Shields completed her ophthalmology training at Wills Eye Hospital in Philadelphia in 1987 and subsequently did fellowship training in ocular oncology, oculoplastic surgery, and ophthalmic pathology. She is currently Co-Director of the Oncology Service, Wills Eye Hospital, and Professor of Ophthalmology at Thomas Jefferson University in Philadelphia.


Read More >>

She has authored or coauthored 12 textbooks, nearly 1500 articles in major peer-reviewed journals, over 300 textbook chapters, given over 700 lectureships, and many awards. The 5 most prestigious honors include:

The Donders Award (2003) given by the Netherlands Ophthalmological Society every 5 years to an ophthalmologist worldwide who has contributed to the field of ophthalmology.  She was the first woman to receive this award.

The American Academy of Ophthalmology Life Achievement Honor Award (2011) for contributions to the field of ophthalmology.

Induction into the Academic All-American Hall of Fame (2011) for lifetime success in athleticism  and career.

President of the International Society of Ocular Oncology (2013-2015) – This is the largest international society of clinicians and basic scientists interested in ocular tumors.

Ophthalmology Power List 2014 and 2016 – Nominated by peers as one of the top 100 leaders in the field of ophthalmology.

Dr. Carol Shields is a member of numerous ocular oncology, pathology, and retina societies. She serves on the editorial or advisory board of 27 journals, including JAMA Ophthalmology. She practices Ocular Oncology on a full time basis with her husband, Dr. Jerry Shields and associates on the Oncology Service at Wills Eye Hospital. Each year the Oncology Service manages approximately 500 patients with uveal melanoma, 120 patients with retinoblastoma, and numerous other intraocular, orbital, and conjunctival tumors from the United States and abroad. She and her husband Jerry are the parents of 7 children, ranging in age from 16 to 28 years.

Dr. Bertil Damato, MD, PhD, FRCOphth

Dr. Bertil Damato, MD, PhD, FRCOphth

Director of the Ocular Oncology Service at the University of California San Francisco

Dr. Bertil Damato is Director of the Ocular Oncology Service at the University of California San Francisco, practicing both adult and pediatric ocular oncology. He received his undergraduate training in Malta, his country of birth, and his postgraduate training at the University of Glasgow, Scotland. In 1993, he established the Ocular Oncology Service at the Royal Liverpool University Hospital, England, where he directed the service until 2013.


Read More >>

Dr. Damato has published more than 240 papers, 65 chapters and 7 textbooks, one as sole author. He has received several awards, including the Bjerrum Medal (Denmark), Cohen Medal (South Africa), Ashton Medal (UK) and the Watson Medal (UK). He has served as President of the European Ophthalmic Oncology Group, European Vision and Eye Research Association, and the International Society of Ocular Oncology.

Dr Santosh G Honavar, MD, FACS

Dr Santosh G Honavar, MD, FACS

Director, Medical Services (CFS Group)
Director, CFS Education
Director, National Retinoblastoma Foundation
Director, Dept of Ophthalmic Plastic Surgery and Ocular Oncology
Centre for Sight, Road No 2, Banjara Hills, Hyderabad 500034


Read More >>

Dr Honavar had his medical education at the Bangalore Medical College. He was the Best Graduate of the Bangalore University. He received residency training in Ophthalmology, followed by fellowship in Ophthalmic Plastic Surgery and Ocular Oncology at the Dr Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi. He was adjudged the Best Resident. Dr Honavar further trained in Ocular Oncology and was mentored by Profs JA Shields and CL Shields at the Wills Eye Hospital, Philadelphia, PA, USA. He thereafter established the Ocular Oncology Service at the LV Prasad Eye Institute, Hyderabad, the first such facility in the country. The comprehensive multispecialty Children’s Eye Cancer Center that he has established has done pioneering work and is now recognized as one of the best in the World. He currently leads the Medical Services team at the Centre for Sight, and also heads CFS Education. Dr Honavar leads the International Council of Ophthalmology fellowship curriculum development committee and the oculoplasty section of the residency curriculum development committee, while being on its Advisory Board. He is currently the Secretary of the Oculoplastics Association of India and the  President of Asia Pacific Society of Ocular Oncology and Pathology.

His  research interests comprise of tumors of the ocular surface, orbit and retinoblastoma. Dr Honavar has extensively published in peer reviewed journals (over 200 manuscripts) and has written several book chapters, while being a reviewer for all the major journals in ophthalmology and oncology.  Dr Honavar’s overall research contributions that have had very significant impact on the diagnosis and management of retinoblastoma and its outcome. 

Some of the major awards and honors to his credit include seven Gold Medals and the Best Graduate Award by the Bangalore University for excellence in MBBS, 1988;  Col Rangachari Gold Medal by the AIOS, 1992;  Best Resident Award by the Dr Rajendra Prasad Center for Ophthalmic Sciences, All India Institute of Medical Sciences, New Delhi, 1995; ARVO-Santen International Fellowship by the ARVO, 1996; Zeigler International Fellowship by the Orbis International, New York, USA, 1999; Young Scientist Award by the Indian Society of Oncology, 2000; Best of Show Award for the video film by the American Academy of Ophthalmology, 2002 and 2006; Achievement Award by the American Academy of Ophthalmology, 2002; Dr Siva Reddy International Award by the AIOS, 2007, Shanti Swarup Bhatnagar Award by the Government of India, 2010, Prof MA Matin Award by the Bangladesh Academy of Ophthalmology, 2013 and Jerry Shields International Award by APAO, November 2013.

 

Jerry A. Shields, M.D.

Jerry A. Shields, M.D.

Jerry A. Shields, M.D. is director of Oncology Service at Wills Eye Hospital in Philadelphia. He was a founder and first president of ISOO. He has authored or co-authored  1364 articles in scientific journals and  616 textbook chapters. He has given 1560 lectures including 82 named lectures.  In 2012, he was honored by the establishment of the Jerry Shields Lecture presented annually at the Asian Pacific Society of Ophthalmology.


Read More >>

In March 2013 he received the National Physician of the year award (named top doctor in America) by Castle Connolly Medical LTD. He was 2014 recipient of the annual Laureate Award. This is most prestigious honor given to one person annually by the American Academy of Ophthalmology.

Dr. Shields is married to Dr. Carol L. Shields M.D. who has also received numerous academic honors and awards. They have 7 children ranging from 28 to 16 years of age.

 
  1. Cutaneous Melanoma / Ocular Melanoma (Combined ISOO / RANZCO NSW ASM Session)

Dr Bita Esmaeli

Dr Bita Esmaeli

Dr Bita Esmaeli is a Professor of Ophthalmology in the Department of Plastic Surgery at The University of Texas M. D. Anderson Cancer Center, where she has had an orbital oncology and oncologic ophthalmic plastic surgery practice since 1998.

Dr Esmaeli’s practice focus is surgical treatment of orbital tumors, lacrimal gland carcinomas, eyelid cancers, melanoma of eyelid and conjunctiva, and reconstructive surgery in the periocular region including lacrimal surgery.


Read More >>

Dr Esmaeli has authored over 180 peer-reviewed manuscripts, over 55 invited articles and book chapters, has spearheaded several clinical trials, and has participated in numerous research protocols at M. D. Anderson Cancer Center. She has received many prestigious awards and honors including the Merrill Reeh Pathology Award and the Research Award from the American Society of Ophthalmic Plastic and Reconstructive Surgery, the American Academy of Ophthalmology Senior Achievement Award, Best Doctors in America, and Top Doctors Award. Dr Esmaeli is a member of the American Ophthalmologic Society.

Dr Esmaeli 's research interests include molecular signature of ocular and orbital tumors, tissue banking,  eye and vision-sparing treatment strategies for orbital and adnexal cancers, and ocular side effects of cancer therapy.

Dr. Esmaeli helped establish the Ophthalmology Service as a comprehensive full-time service at M. D. Anderson Cancer Center in 1998. She served as the Director of Service from 1998 to 2001 and the Chief of Ophthalmology from 2001 to 2004. She is the Program Director for an ASOPRS-sponsored fellowship in oculoplastic surgery and orbital oncology at M. D. Anderson Cancer Center. She currently chairs the Graduate Medical Education Committee at MD Anderson Cancer Center.

Victoria Cohen

Victoria Cohen

Victoria Cohen is Director of the National Ocular Oncology Service in London and Chair of the Ocular Oncology Multidisciplinary Team. Ten years ago she was appointed as Consultant Ocular Oncologist at Moorfields and St Barthololmew's Hospital. Significant achievements in her consultant career include the introduction of cytogenetic testing of uveal melanoma and sentinel node biopsy for conjunctival tumours, the initiation of Multidisciplinary Team working including data collection and development of the first UK National Guidelines for the management of Uveal Melanoma, which achieved NICE accreditation in 2015.


Read More >>

Her training in Ocular Oncology began in Sheffield in 1996. Victoria undertook two London Ocular Oncology fellowships with John Hungerford in 2003 and 2005. She was awarded the Pzifer Ophthalmic Fellowship to undertake a year of Ocular Oncology in the USA and trained at Wills Eye Hospital, Philadelphia, MD Anderson, Texas and Memorial Sloane Kettering, New York.

Victoria is actively involved in research, teaching and training. She is a member of faculty for the American Academy of Ophthalmologists, the Wills Eye Fellows Association, Euroretina, the European Ocular Oncology Group and the International Society of Ocular Oncology. She is widely published in the field of Ocular Oncology. She now runs an International Fellowship program in Ocular Oncology, training individuals from all around the world.

Hans E. Grossniklaus MD

Hans E. Grossniklaus MD

F. Phinizy Calhoun Jr. Professor of Ophthalmology and Pathology, Vice-Chairman, Department of Ophthalmology. 

Dr. Grossniklaus received his MD degree from Ohio State University, followed by residencies in ophthalmology and pathology at Case Western Reserve University and fellowships in ophthalmic pathology at the Wilmer Institute and the Armed Forces Institute of Pathology. He is board certified in ophthalmology and pathology.   He has been on the faculty at Emory University and served as director of the L.F. Montgomery Ophthalmic Pathology Laboratory since 1989 and founding director of the Ocular Oncology Service since 2007 where he actively sees patients and performs surgery.


Read More >>

He is a member of numerous national and international organizations, including the Past-President and current Executive Vice President of the American Ophthalmological Society (AOS), Past-President of the American Association of Ocular Oncologists and Pathologists and Verhoeff-Zimmerman Society, and member of Academia Ophthalmological Internationalis (AOI).  He has served on 14 local committees and 5 national/international committees, including NIH NEI and NCI Study Sections.  He is on the editorial board of five journals, including and founding Co-Editor in Chief of Ocular Oncology and Pathology.  He has received support from 11 federally funded grants including being PI with continuous support of NCI ocular oncology grants.  He has served as the structural biology module director of the ophthalmology departmental core grant for over 20 years.  He has received support from eleven private grants.  He has been a visiting professor at 20 institutes including the Massachusetts Eye and Ear Infirmary, Wilmer Institute, Jules Stein Institute, and Wills Eye Hospital.  He has been an invited participant in over 50 national and international conferences including lectures in Australia, Brazil, Germany, Japan, Korea and Sweden.  He has received numerous awards, including the AAO Senior Achievement Award, the outstanding former Heed Fellow Award and the W. Richard Green Lecture Award.  He has authored/co-authored nearly papers published in peer reviewed journals and 12 books/monographs.  As director of the L.F. Montgomery Laboratory, a world premier eye pathology laboratory, he has signed out approximately 60,000 cases.  He has trained 20 fellows from around the world, most of whom now hold academic positions.  He has trained dozens of residents and medical students. He has received three teaching awards and a teaching grant.  His research interests are pathobiology of retinoblastoma and uveal melanoma and local therapies for these tumors.

Professor Georgina Long

Professor Georgina Long

Medical Oncologist, Melanoma Institute Australia 

BSc PhD MBBS FRACP, is Chair of Melanoma Medical Oncology and Translational Research at Melanoma Institute Australia (MIA) and Royal North Shore Hospital, The University of Sydney. She leads an extensive clinical trials team and laboratory at MIA, with a focus on targeted therapies and immuno-oncology in melanoma. She is principal investigator on phase I, II and III clinical trials in adjuvant and metastatic melanoma, including trials in patients with active brain metastases. She is the chief investigator on NHMRC funded research into the molecular biology of melanoma, with a particular interest in clinical and tissue biomarker correlates of systemic therapy sensitivity and resistance.


Read More >>

In recognition of her ground breaking research, Professor Long has received a number of awards, including the prestigious Sir Zelman Cowen Universities Fund Prize for Discovery in Medical Research in 2016, and a number of recent CINSW Premier’s Awards for Outstanding Cancer Research: In 2014, she was awarded the Wildfire Award for the most highly-cited, original, peer-reviewed article published in 2011; and in 2013 she was named the Outstanding Cancer Research Fellow.

She is the author of over 120 peer-reviewed publications in clinical and translational research in melanoma since 2011, including the New England Journal of Medicine, Lancet, Lancet Oncology, Journal of Clinical Oncology and Cancer Discovery. Professor Long has presented her work at international conferences and meetings on more than 120 occasions.  She is Chair of the ASCO Scientific Committee for melanoma and skin cancer, is medical oncology lead for the Australian Melanoma Management Guidelines Committee, is on the editorial boards of several high-impact journals, and is a member of the Melanoma Expert Panel for AJCC Cancer Staging System 8th edition.

Professor Long was awarded the University Medal in Organic Chemistry. She subsequently completed her PhD in Chemistry in the field of anti-cancer agents and their binding to DNA. She then moved to the USA to take up a Fulbright Postdoctoral Fellowship at Scripps Research Institute, exploring nanotechnology in cancer treatment, before returning to Australia to complete her MBBS (Hons). Professor Long became a Fellow of the Australasian College of Physicians in January 2008, specialising in medical oncology.

 

Richard A Scolyer

Professor Richard A Scolyer

Consultant Pathologist, Melanoma Institute Australia

Consultant Pathologist and Co-Director of Research, Melanoma Institute Australia

Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney

Clinical Professor, Sydney Medical School, The University of Sydney

National Health and Medical Research Council Practitioner Fellow


Read More >>

Richard Scolyer studied medicine at the University of Tasmania (BMedSci, MBBS). After completing clinical training in Australia and overseas, he undertook pathology training at the Canberra Hospital and at the Royal Prince Alfred Hospital leading to Fellowship of the Royal College of Pathologists of Australasia. Richard is currently Consultant Pathologist and Co-Director of Research, Melanoma Institute Australia; Senior Staff Specialist, Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney; and Clinical Professor, The University of Sydney.

Richard has presented on more than 150 occasions at conferences throughout the world, and is a co-author of more than 400 articles and book chapters on melanocytic pathology and related research. In 2006, Richard was awarded the degree of Doctor of Medicine by The University of Sydney for his thesis of publications on melanocytic pathology. He received a NSW Premier's Award for Outstanding Cancer Research in 2009 and 2012. He is also an editorial board member of the American Journal of Surgical Pathology, a member of the International Editorial Advisory Board of Histopathology and Senior Associate Editor of Pathology. In 2013, Richard was appointed Vice Chair of the Melanoma Expert Panel of the American Joint Committee on Cancer (AJCC) for the 8th edition of their Cancer Staging System. He is currently President-Elect of the Australasian Division of the International Academy of Pathology. Together with other MIA colleagues, Richard is chief investigator on 5 year program grants from both the NHMRC and CINSW and he also has a personal Fellowship from the NHMRC.

Professor John Thompson

Professor John Thompson

Executive Director, Melanoma Institute Australia

Professor John Thompson is the Executive Director and Research Director of Melanoma Institute Australia (MIA), one of the world’s largest melanoma treatment and research centres.  He completed his surgical training at the Royal Prince Alfred Hospital (RPAH) in Sydney and undertook three years of clinical and research work in the Nuffield Department of Surgery, University of Oxford.  He succeeded Professor Bill McCarthy as Executive Director of MIA (then the Sydney Melanoma Unit) and Head of the Melanoma and Surgical Oncology Department of RPAH in 1988, and in 1999 he was appointed as the Professor of Melanoma and Surgical Oncology at the University of Sydney.


Read More >>

He is the author of over 700 peer-reviewed scientific articles in the medical literature, as well as numerous book chapters, review articles and monographs.  He is a Fellow of the Royal Australasian College of Surgeons and the American College of Surgeons, and is an active member of the Society of Surgical Oncology.  In 2014 he was made an Officer of the Order of Australia (AO) for distinguished service to medicine in the field of oncology research, particularly melanoma, to international and national professional organisations, and to medical education.  In 2015 he was made an Honorary Fellow of the American Surgical Association and elected as an inaugural Fellow of the Australian Academy of Health and Medical Sciences.  His principal current research interests are in the fields of lymphatic mapping and regional node management of patients with melanoma and other malignancies, and local and regional therapies for recurrent and advanced limb tumours.

 
 

© Copyright 2015. Site by Invisage